2026-04-17T03:44:01Zhttps://recercat.cat/oai/request

oai:recercat.cat:2072/4713242024-11-04T06:40:35Zcom_2072_98col_2072_378192

00925njm 22002777a 4500 dc Basurte-Villamor, Ignacio author Vega, Pablo author Roncero, Carlos author Martínez-Raga, José author Grau-López, Lara author Aguilar, Lourdes author Torrens, Marta author Szerman, Nestor author Universitat Autònoma de Barcelona author 2022 Limited studies have evaluated the effectiveness of vortioxetine in real-world settings, and none of them has involved patients with dual depression (major depressive disorder [MDD] and substance use disorder [SUD]). The objective of the study was to describe the effectiveness of vortioxetine in clinical practice and determine its effect on affective symptoms, cognitive function, quality of life, and substance use in patients with MDD and SUD. Post-authorization, retrospective, multicenter, descriptive, and observational study in 80 patients with MDD and SUD receiving a maintenance treatment with vortioxetine for six months between January 2017 and April 2021. Compared with baseline, scores significantly decreased after 3 and 6 months of treatment in the Montgomery-Åsberg Depression Rating Scale total (from 28.9 to 17.7 and 12.0), and global functional impairment of the Sheehan Disability Inventory (from 26.3 to 19.1 and 16.7). The number of correct answers in the symbol digit modalities test significantly improved during vortioxetine treatment (from 40.4 to 43.8 and 48.4). Regarding the clinical global impression scale, the score for disease severity significantly decreased from 3.8 to 3.0 and 2.4. Compared with baseline, there was a significant reduction in consumption of practically all substances, especially of alcohol, cannabis, and cocaine. Vortioxetine was effective in clinical practice for alleviating depressive symptoms and functional impairment, and in improving cognitive and executive functions and disease severity in patients with MDD and SUD. Moreover, the treatment with vortioxetine favored a reduction in substance use and the severity of the SUDs. http://hdl.handle.net/2072/471324 Dual disorder Major depressive disorder Major dual depressive disorder Real-world evidence Substance use disorder Vortioxetine A Feasibility Study of Patients with Major Depression and Substance Use Disorders : Vortioxetine as Maintenance Treatment